|
J. Biol. Chem., Vol. 261, Issue 24, 11028-11037, 08, 1986
ATP regulation of the human red cell sugar transporter
A Carruthers
Purified human red blood cell sugar transport protein intrinsic tryptophan
fluorescence is quenched by D-glucose and 4,6-ethylidene glucose (sugars
that bind to the transport), phloretin and cytochalasin B (transport
inhibitors), and ATP. Cytochalasin B-induced quenching is a simple
saturable phenomenon with Kd app of 0.15 microM and maximum capacity of
0.85 cytochalasin B binding sites per transporter. Sugar- induced quenching
consists of two saturable components characterized by low and high Kd app
binding parameters. These binding sites appear to correspond to influx and
efflux transport sites, respectively, and coexist within the transporter
molecule. ATP-induced quenching is also a simple saturable process with Kd
app of 50 microM. Indirect estimates suggest that the ratio of ATP-binding
sites per transporter is 0.87:1. ATP reduces the low Kd app and increases
the high Kd app for sugar- induced fluorescence quenching. This effect is
half-maximal at 45 microM ATP. ATP produces a 4-fold reduction in Km and
2.4-fold reduction in Vmax for cytochalasin B-inhibitable D-glucose efflux
from inside-out red cell membrane vesicles (IOVs). This effect on transport
is half-maximal at 45 microM ATP. AMP, ADP, alpha, beta- methyleneadenosine
5'-triphosphate, and beta, gamma-methyleneadenosine 5'-triphosphate at 1 mM
are without effect on efflux of D-glucose from IOVs. ATP modulation of Km
for D-glucose efflux from IOVs is immediate in onset and recovery. ATP
inhibition of Vmax for D-glucose exit is complete within 5-15 min and is
only partly reversed following 30-min incubation in ATP-free medium. These
findings suggest that the human red cell sugar transport protein contains a
nucleotide-binding site(s) through which ATP modifies the catalytic
properties of the transporter.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. K. Khera, C. H. Joiner, A. Carruthers, C. J. Lindsell, E. P. Smith, R. S. Franco, Y. R. Holmes, and R. M. Cohen
Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation
Diabetes,
September 1, 2008;
57(9):
2445 - 2452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Leitch and A. Carruthers
ATP-dependent sugar transport complexity in human erythrocytes
Am J Physiol Cell Physiol,
February 1, 2007;
292(2):
C974 - C986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dauterive, S. Laroux, R. C. Bunn, A. Chaisson, T. Sanson, and B. C. Reed
C-terminal Mutations That Alter the Turnover Number for 3-O-Methylglucose Transport by GLUT1 and GLUT4
J. Biol. Chem.,
May 10, 1996;
271(19):
11414 - 11421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Vera, A. M. Reyes, J. G. Cárcamo, F. V. Velásquez, C. I. Rivas, R. H. Zhang, P. Strobel, R. Iribarren, H. I. Scher, J. C. Slebe, et al.
Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1
J. Biol. Chem.,
April 12, 1996;
271(15):
8719 - 8724.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|